Walgreens is seeking volunteers who are still in need of their annual COVID-19 and Flu shots.
Join us for an exciting clinical study on investigational COVID-19 and flu combo shot aimed at improving and simplifying the annual vaccination process. Your participation could help make vaccinations easier and more accessible for everyone!
Study Overview
Why is this study important?
Walgreens, in partnership with Sanofi, is evaluating the effectiveness of an investigational combination COVID-19 and flu shot to streamline the vaccination process. The goal of this study is to simplify annual vaccinations, making it easier for everyone to stay protected. Join us in shaping the future of healthcare!
Eligibility Criteria
You may be eligible if:
You are 50 years or older
You have not yet received your COVID-19/Flu vaccines this year (past 6 months)
You have already received your primary COVID-19 vaccinations and at least 1 booster dose (greater than 6 months ago)
There are additional study criteria that the study team will discuss with you.
Taking part in this study involves:
Learning about the details of the study and giving your consent to participate
Participation in this study lasts for about 12 months
Receiving 2 shots at the same visit: one each into the left and right muscles of your upper arms
If you qualify and choose to participate in this study, you will be randomly assigned to a group. The group that you are assigned to determines the dosage of your study vaccinations.
Frequently Asked Questions
-
Clinical research is the process of developing medicines or therapies to possibly prevent, treat, or help with diseases. Before a medicine can become available, it must be tested in a series of clinical studies to understand if it is safe and effective. With the help of clinical study participants, researchers are able to find out if and how potential new medicines work.
-
Participating in this trial could offer you the opportunity to receive your annual vaccines in one study injection. It allows you to take an active role in your own health care, contributing to research that could lead to advancements in vaccines and could benefit thousands of people with this condition in the future.
-
In this clinical trial, you can expect a thorough and supportive process starting with an informed consent session, where all aspects of the study, including its purpose, procedures, potential benefits, and risks, will be explained in detail. Following your informed consent, you'll undergo a screening process to ensure your eligibility. This includes a comprehensive review of your medical history, a series of laboratory tests, and a physical examination, focusing on your overall health status.
You'll also receive the study drug and detailed instructions on its administration.
-
Yes. You can decide to stop at any time. Just tell the study researcher if you wish to stop being in the study. You do not need to give a reason why you want to stop participating.
-
Participants may be eligible for compensation up to $300 for their time and travel expenses related to the study. Details will be provided upon confirming eligibility.